Study of new treatment for microscopic colitis in remission
Part of Digestive system clinical trials.
This study tests whether a new medication (SAR444336) can help adults with microscopic colitis stay in remission longer. It may be an option if you are already taking budesonide and have had flares in the past 8 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of microscopic colitis (any type).
- You are currently taking budesonide to control your colitis.
- You have had at least one colitis flare in the last 8 months that needed treatment with budesonide.
- Your colitis symptoms have been under control (clinical remission) for at least 2 weeks before the study starts.
- You do not have other inflammatory bowel diseases like Crohn's or ulcerative colitis, or a history of certain serious health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different forms of the drug budesonide (a steroid that reduces inflammation in the gut) to see which works better for easing diarrhea and other symptoms of microscopic colitis. If you have microscopic colitis and are experiencing symptoms, this study could help you find an effective treatment.
This trial tests whether an oral antibiotic called rifaximin can improve symptoms during a microscopic colitis flare. It aims to see if it is safe and effective for people whose colitis was confirmed by colon biopsy.
This trial tests a new treatment for people with ulcerative colitis (UC) whose disease is active despite taking only mesalamine or sulfasalazine. It aims to find a therapy that can reduce inflammation and improve symptoms.
This trial tests a new medicine to see if it's safe for people with moderate to severe ulcerative colitis. It also tests the medicine in healthy volunteers to check for side effects. If you have ulcerative colitis, this might offer a new treatment option.
This study tests an investigational medication called LY4268989 for adults with moderate to severe ulcerative colitis (UC). It's for people who have tried other treatments without success. The goal is to see if the drug can reduce inflammation and improve symptoms.
This study tests a new medication called BI 3032950 for people with ulcerative colitis who have already tried other advanced treatments (biologics or targeted therapies) that didn't work well enough or caused problems. The goal is to see if the new drug is safe and helps control inflammation in the colon.
Hear when a new Microscopic Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.